AbbVie Inc. (ABBV)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
After hours:
| Previous close | 164.66 |
| Open | 165.02 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's range | 163.26 - 166.60 |
| 52-week range | 130.96 - 182.89 |
| Volume | |
| Avg. volume | 5,637,629 |
| Market cap | 294.672B |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | 61.18 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 6.20 (3.77%) |
| Ex-dividend date | 12 Apr 2024 |
| 1y target est | N/A |
- Investor's Business Daily
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
AbbVie stock has slumped 10% off its record high in March and is facing increasingly steep competition for its biggest moneymaker, Humira.
- Zacks
Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
J&J (JNJ) posts mixed first-quarter 2024 results. Lilly's (LLY) tirzepatide meets key goals in late-stage studies for obstructive sleep apnea.
© 2024 Yahoo. All rights reserved.